"This is one of our largest community organisation focused grants for viral hepatitis in Australia and will help empower communities to tackle some of the fundamental obstacles to elimination by increasing awareness, testing and linkage to care across Australia,” said Gilead Australia and New Zealand general manager Jaime McCoy.
Community organisations receive grants via Gilead's global ALL4LIVER program
April 22, 2024 Latest NewsBioPharma
Latest Video
New Stories
-
NDIS keeps growing but signs emerge that reforms are starting to work
July 17, 2025 - - Latest News -
USTR launches new investigation, with minimal ambition on pharmaceuticals
July 17, 2025 - - Latest News -
New Zealand starting to benefit after lifting advertising prohibition
July 17, 2025 - - Latest News -
Mark Butler restates support for health technology assessment reform
July 16, 2025 - - Latest News -
Brandon BioCatalyst welcomes the inclusion of its CUREator in new program
July 16, 2025 - - Australian Biotech -
Cancer Australia launches research program targeting early-onset cancers
July 16, 2025 - - Latest News -
Imugene completes significant placement and launches share purchase plan
July 16, 2025 - - Australian Biotech